Heavy Chain Only Antibodies: A New Paradigm in Personalized HER2+ Breast Cancer Therapy
(2013)
Journal Article
Moghimi, S., Rahbarizadeh, F., Ahmadvand, D., & Parhamifar, L. (2013). Heavy Chain Only Antibodies: A New Paradigm in Personalized HER2+ Breast Cancer Therapy. BioImpacts, 3(1), 1-4. https://doi.org/10.5681/bi.2013.009
Unlike conventional antibodies, heavy chain only antibodies derived from camel contain a single variable domain (VHH) and two constant domains (CH2 and CH3). Cloned and isolated VHHs possess unique properties that enable them to excel conventional th... Read More about Heavy Chain Only Antibodies: A New Paradigm in Personalized HER2+ Breast Cancer Therapy.